ABBOTT
Recent news mentioning ABBOTT
- — Real Estate Expert Nathan Abbott Explains Property Type Considerations in HelloNation
- — STEIN MITCHELL ATTORNEYS REPRESENT WHISTLEBLOWERS IN NEARLY $385 MILLION ABBOTT INFANT FORMULA SETTLEMENT
- — Abbott reaches agreement with Department of Justice to resolve claims relating to 2022 infant formula recall
- — Two Medical Device Dividend Giants, One Better Buy: Medtronic vs. Abbott
- — Arkansas Kidney Champion Bob Abbott Enters Hall of Fame
- — HelloNation Article Explains Gulf Area Property Inspections, Featuring Real Estate Expert Nathan Abbott
- — Dexcom, Abbott await Medicare coverage expansion for CGMs
- — Pfizer vs. Abbott: Which Dividend Healthcare Stock Offers the Better Risk-Reward?
- — Abbott receives FDA authorization for world's first dual glucose-ketone sensing technology for people with diabetes
- — Abbott Pays $670 Million to Settle Formula Claims as Legal Risks Persist
- — Billionaire Ken Griffin Just Loaded Up on AbbVie and Abbott. Here's Whether Investors Should Follow His Lead.
- — James T. Brunz, MD Recognized by Abbott Neuromodulation as a Spinal Cord Stimulation Center of Excellence Physician